230 related articles for article (PubMed ID: 8904135)
1. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
Imaizumi T; Ishikawa H; Hashimoto I
J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
[No Abstract] [Full Text] [Related]
2. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
Ito K; Ito M
J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
Terui T; Tagami H
J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
[No Abstract] [Full Text] [Related]
4. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
Muranaka H; Yokoyama M
J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
[No Abstract] [Full Text] [Related]
5. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
Imanaka H; Kitahara T; Yoshinaga M; Miyata K
J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
[No Abstract] [Full Text] [Related]
6. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
Fulton B; Perry CM
Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
Li JT; Hou J; Kao L
Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of infectious complications affecting the skin and soft tissues with cefpodoxime proxetil].
Vyhnánek F; Lochmann O
Epidemiol Mikrobiol Imunol; 1996 May; 45(2):68-70. PubMed ID: 8756403
[TBL] [Abstract][Full Text] [Related]
9. Once-a-day therapy of cefpodoxime proxetil for respiratory tract infections.
Sawae Y; Ninomiya K; Sumida I; Inoue T; Takaki K; Okada K; Kumagai Y; Ishimaru T; Shimono N; Misumi H
J Chemother; 1995 Nov; 7 Suppl 4():134-6. PubMed ID: 8904134
[No Abstract] [Full Text] [Related]
10. [Cefpodoxime].
Enferm Infecc Microbiol Clin; 1995; 13(7):437-8. PubMed ID: 8519823
[No Abstract] [Full Text] [Related]
11. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
[TBL] [Abstract][Full Text] [Related]
12. [Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice].
Brambilla C; Benhamou D; Guérin JC; Kelkel E; Muir JF; Prud'homme A; Taytard A; Fauche A
Pathol Biol (Paris); 1995 Nov; 43(9):815-24. PubMed ID: 8746104
[TBL] [Abstract][Full Text] [Related]
13. Cefpodoxime proxetil--a new oral cephalosporin.
Med Lett Drugs Ther; 1992 Nov; 34(884):107-8. PubMed ID: 1435506
[No Abstract] [Full Text] [Related]
14. Clinical trials of cefpodoxime proxetil suspension in paediatrics.
Fujii R
Drugs; 1991; 42 Suppl 3():57-60. PubMed ID: 1726209
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study and clinical evaluation of cefpodoxime proxetil in the elderly with impaired renal function.
Ishioka T
J Chemother; 1995 Nov; 7 Suppl 4():122-3. PubMed ID: 8904130
[No Abstract] [Full Text] [Related]
16. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Schatz BS; Karavokiros KT; Taeubel MA; Itokazu GS
Ann Pharmacother; 1996 Mar; 30(3):258-68. PubMed ID: 8833562
[TBL] [Abstract][Full Text] [Related]
17. [Respiratory tract infections in general practice. Cefpodoxime proxetil in patients with risk factors and concomitant illnesses].
Kardos P; Wiese K
MMW Fortschr Med; 2000 Feb; 142(5):41. PubMed ID: 10715939
[No Abstract] [Full Text] [Related]
18. [Reevaluation of current antimicrobials. Cefpodoxime proxetil. Discussion].
Jpn J Antibiot; 1995 Feb; 48(2):183-90. PubMed ID: 7745807
[No Abstract] [Full Text] [Related]
19. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
Stevens DL; Pien F; Drehobl M
Diagn Microbiol Infect Dis; 1993 Feb; 16(2):123-9. PubMed ID: 8467623
[TBL] [Abstract][Full Text] [Related]
20. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections.
Cox CE; Graveline JF; Luongo JM
Drugs; 1991; 42 Suppl 3():41-50. PubMed ID: 1726207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
